Emerald Acquisition’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Emerald Acquisition’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$1K	Buy	+200	New	+$1.32K	﹤0.01%	2979

Other funds holding JNP

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Emerald Acquisition's JNP Position: Q3 2016 in Review

Emerald Acquisition opened a new position in Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2016: 200 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2979 among its holdings.

46 funds tracked by Wall St. Rank hold JNP as of Q3 2016.

Emerald Acquisition held 200 shares of Juniper Pharmaceuticals, Inc. Common Stock worth $1K as of Q3 2016.
Juniper Pharmaceuticals, Inc. Common Stock was a new Emerald Acquisition position in Q3 2016.
Juniper Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2979 holding.
46 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.